Tags

Type your tag names separated by a space and hit enter

Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure.
Am J Cardiol. 2000 Feb 15; 85(4):506-8, A11.AJ

Abstract

The use of phosphodiesterase inhibitors such as milrinone in the treatment of severe heart failure is frequently restricted because they cause vasodilation and hypotension. In patients with decompensated heart failure with hypotension after treatment with milrinone, low doses of vasopressin restored blood pressure without inhibiting the inotropic effect of milrinone.

Authors+Show Affiliations

Department of Medicine, Columbia University, College of Physicians & Surgeons, New York, New York, USA.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

10728962

Citation

Gold, J, et al. "Vasopressin in the Treatment of Milrinone-induced Hypotension in Severe Heart Failure." The American Journal of Cardiology, vol. 85, no. 4, 2000, pp. 506-8, A11.
Gold J, Cullinane S, Chen J, et al. Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure. Am J Cardiol. 2000;85(4):506-8, A11.
Gold, J., Cullinane, S., Chen, J., Seo, S., Oz, M. C., Oliver, J. A., & Landry, D. W. (2000). Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure. The American Journal of Cardiology, 85(4), 506-8, A11.
Gold J, et al. Vasopressin in the Treatment of Milrinone-induced Hypotension in Severe Heart Failure. Am J Cardiol. 2000 Feb 15;85(4):506-8, A11. PubMed PMID: 10728962.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure. AU - Gold,J, AU - Cullinane,S, AU - Chen,J, AU - Seo,S, AU - Oz,M C, AU - Oliver,J A, AU - Landry,D W, PY - 2000/3/23/pubmed PY - 2000/3/23/medline PY - 2000/3/23/entrez SP - 506-8, A11 JF - The American journal of cardiology JO - Am J Cardiol VL - 85 IS - 4 N2 - The use of phosphodiesterase inhibitors such as milrinone in the treatment of severe heart failure is frequently restricted because they cause vasodilation and hypotension. In patients with decompensated heart failure with hypotension after treatment with milrinone, low doses of vasopressin restored blood pressure without inhibiting the inotropic effect of milrinone. SN - 0002-9149 UR - https://www.unboundmedicine.com/medline/citation/10728962/Vasopressin_in_the_treatment_of_milrinone_induced_hypotension_in_severe_heart_failure_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0002-9149(99)00783-3 DB - PRIME DP - Unbound Medicine ER -